January Vertex Update- Latest VX809, VX661 and Kalydeco with gating & R117H info

I recently wrote a blog post about the latest Vertex news (includes info from the Dec and Jan press releases & investor conferences). Since I wrote this post it has also been announced that the combination therapy VX661/Ivacaftor has been granted breakthrough FDA designation.

http://sixtyfiverosesblog.wordpress.com/2014/01/29/january-vertex-update/

Source: Cystic Fibrosis CFTR Modulation and Gene Therapy Forum - February 3, 2014 Category: Respiratory Medicine Authors: GenH Tags: CFTR Modulation and Gene Therapy Talk Source Type: forums